Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 2/2019

14.11.2018 | Original Article

Left-sided infective endocarditis caused by Streptococcus agalactiae: rare and serious

verfasst von: Radka Ivanova-Georgieva, Josefa Ruiz-Morales, Emilio García-Cabrera, María Victoria García-López, Juan Gálvez-Acebal, Antonio Plata-Ciezar, Javier de la Torre Lima, Carmen Hidalgo-Tenorio, Francisco Javier Martínez-Marcos, David Vinuesa García, Rafael Luque, Arístides de Alarcón González

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

A comparative study of the behaviour of left-sided infective endocarditis (left-sided IE) due to Streptococcus agalactiae (GBS) with left-sided IE caused by Staphylococcus aureus (SA). A prospective, multicentre cohort study in eight public hospitals in Spain, from January 1984 to December 2015; comparative analysis and factors associated with mortality. In total, there were 1754 episodes of left-sided IE; 41 (2.3%) caused by GBS vs. 344 (19.6%) due to SA, definitive IE 39 vs. 324 cases, males, 25 vs. 213, respectively. There were no differences in age or comorbidity, and healthcare-associated acquirement was 10% vs. 43%, p 0.001. Transthoracic echocardiogram (TTE) was performed in 95% vs. 96.8% and a transesophageal echocardiogram (TEE) in 61% vs. 56%. Vegetations were detected in 80% and measured > 1 cm in a similar proportion. It affected native valves in 85.4% vs. 82.6% and late prosthetic valve in 14.6% vs. 9.6%. The course was acute in both groups. There were more skin manifestations in SA left-sided IE, 7.3% vs. 32%, p 0.001. Both groups had similar complications, but in SA, there was more renal failure, 24% vs. 45%, p 0.010. Surgical risk and operated patients were similar. Mortality was proportionally higher in the SA group, without significance 29% vs. 43% (150), p 0.09. Heart failure, septic shock and neurological deterioration conditioned mortality: HR 1.96, 1.69 and 1.37 (CI 95% 1.40–2.73; 1.19–2.39 and 0.99–1.88 respectively) and to a lesser degree SA as aetiology agent and age. Left-sided IE caused by GBS is similar in severity to left-sided IE caused by SA.
Literatur
1.
Zurück zum Zitat Gallagher PG, Watanakunakorn CH (1986) Group B streptococcal endocarditis: report of seven cases and review of the literature 1962-1985. Rev Infect Dis 9:175–188CrossRef Gallagher PG, Watanakunakorn CH (1986) Group B streptococcal endocarditis: report of seven cases and review of the literature 1962-1985. Rev Infect Dis 9:175–188CrossRef
2.
Zurück zum Zitat Schully BE, Spriggs D, Neu H (1987) Streptococcus agalactiae (group B) endocarditis. A description of twelve cases and review of the literature. Infection 3:21–23 Schully BE, Spriggs D, Neu H (1987) Streptococcus agalactiae (group B) endocarditis. A description of twelve cases and review of the literature. Infection 3:21–23
3.
Zurück zum Zitat Pringle SD, McCartney AC, Marshall AS, Cobb S (1989) Infective endocarditis caused by Streptococcus agalactiae. Int J Cardiol 24:179–183CrossRefPubMed Pringle SD, McCartney AC, Marshall AS, Cobb S (1989) Infective endocarditis caused by Streptococcus agalactiae. Int J Cardiol 24:179–183CrossRefPubMed
4.
Zurück zum Zitat Marrón A, Carratalá J, Peña C, Roson B, Tubau F, Rufi G (1997) Endocarditis caused by group B streptococci in adults. Enferm Infecc Microbiol Clin 15:147–150PubMed Marrón A, Carratalá J, Peña C, Roson B, Tubau F, Rufi G (1997) Endocarditis caused by group B streptococci in adults. Enferm Infecc Microbiol Clin 15:147–150PubMed
5.
Zurück zum Zitat Rollan MJ, San Roman JA, Vilacosta I, Sarria C, Lopez J, Acuña M et al (2003) Clinical profile of Streptococcus agalactiae native valve endocarditis. Am Heart J 146:1095–1098CrossRefPubMed Rollan MJ, San Roman JA, Vilacosta I, Sarria C, Lopez J, Acuña M et al (2003) Clinical profile of Streptococcus agalactiae native valve endocarditis. Am Heart J 146:1095–1098CrossRefPubMed
6.
Zurück zum Zitat Rodriguez Granger J, Ruiz Lopez F, Camacho Muñoz E, Turino J, Sanpedro A, Miranda C (2006) Streptococcus agalactiae infective endocarditis. Enferm Infecc Microbiol Clin 24:379–381CrossRefPubMed Rodriguez Granger J, Ruiz Lopez F, Camacho Muñoz E, Turino J, Sanpedro A, Miranda C (2006) Streptococcus agalactiae infective endocarditis. Enferm Infecc Microbiol Clin 24:379–381CrossRefPubMed
7.
Zurück zum Zitat Sambola A, Miró JM, Tornos MP, Almirante B, Moreno-Torrico A, Gurgui M et al (2002) Streptococcus agalactiae infective endocarditis: analysis of 30 cases and review of literature 1962-1998. Clin Infect Dis 34:1576–1584CrossRefPubMed Sambola A, Miró JM, Tornos MP, Almirante B, Moreno-Torrico A, Gurgui M et al (2002) Streptococcus agalactiae infective endocarditis: analysis of 30 cases and review of literature 1962-1998. Clin Infect Dis 34:1576–1584CrossRefPubMed
8.
Zurück zum Zitat Hurtado-Carrillo L, Hermida JM, Centella T, Dronda F (2008) Infective endocarditis due to Streptococcus agalactiae: clinical profile of an eight-case series. Enferm Infecc Microbiol Clin 26:56–61CrossRefPubMed Hurtado-Carrillo L, Hermida JM, Centella T, Dronda F (2008) Infective endocarditis due to Streptococcus agalactiae: clinical profile of an eight-case series. Enferm Infecc Microbiol Clin 26:56–61CrossRefPubMed
9.
Zurück zum Zitat Ro A (2016) Streptococcus agalactiae infective endocarditis complicated by large vegetations at aortic valve cups along with intracoronary extension: an autopsy case report. Cardiovasc Pathol:221–224 Ro A (2016) Streptococcus agalactiae infective endocarditis complicated by large vegetations at aortic valve cups along with intracoronary extension: an autopsy case report. Cardiovasc Pathol:221–224
10.
Zurück zum Zitat de Chiara B, Peritore A, Sara R, Giannattasio C, Moreo A (2016) Infective endocarditis of an aortic flap due to Streptococcus agalactiae in a patient with Sjögren’s syndrome: an unusual clinical case report. Echocardiography xx:1–2 de Chiara B, Peritore A, Sara R, Giannattasio C, Moreo A (2016) Infective endocarditis of an aortic flap due to Streptococcus agalactiae in a patient with Sjögren’s syndrome: an unusual clinical case report. Echocardiography xx:1–2
11.
Zurück zum Zitat Ivanova Georgieva R, García López MV, Ruiz-Morales J, Martínez-Marcos FJ, Lomas JM, Plata A, Noureddine M, Hidalgo-Tenorio C, Reguera JM, De la Torre Lima J, Gálvez-Aceval J, Márquez M, de Alarcón A, for the Andalusian Group for the Study of Cardiovascular Infections of the Andalusian Society of Infectious Diseases (SAEI) (2010) Streptococcus agalactiae left-sided infective endocarditis. Analysis of 27 cases from a multicentric cohort. J Infect 61:54 5927CrossRefPubMed Ivanova Georgieva R, García López MV, Ruiz-Morales J, Martínez-Marcos FJ, Lomas JM, Plata A, Noureddine M, Hidalgo-Tenorio C, Reguera JM, De la Torre Lima J, Gálvez-Aceval J, Márquez M, de Alarcón A, for the Andalusian Group for the Study of Cardiovascular Infections of the Andalusian Society of Infectious Diseases (SAEI) (2010) Streptococcus agalactiae left-sided infective endocarditis. Analysis of 27 cases from a multicentric cohort. J Infect 61:54 5927CrossRefPubMed
12.
Zurück zum Zitat Sendi P, Ericsson M, Olaison L (2012) Infective endocarditis caused by group B Streptococcus. The role of aminoglycoside-combination. J Infect 64:127–129CrossRefPubMed Sendi P, Ericsson M, Olaison L (2012) Infective endocarditis caused by group B Streptococcus. The role of aminoglycoside-combination. J Infect 64:127–129CrossRefPubMed
13.
Zurück zum Zitat Gálvez-Acebal J, Rodríguez-Baño J, Martínez-Marcos FJ, Reguera JM, Plata A, Ruiz J, Márquez M, Lomas JM, de la Torre-Lima J, Hidalgo-Tenorio C, de Alarcón A, Grupo para el Estudio de las Infecciones Cardiovasculares de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI) (2010) Prognostic factors in left-sided endocarditis: results from the Andalusian multicenter cohort. BMC Infect Dis 10:1–8CrossRef Gálvez-Acebal J, Rodríguez-Baño J, Martínez-Marcos FJ, Reguera JM, Plata A, Ruiz J, Márquez M, Lomas JM, de la Torre-Lima J, Hidalgo-Tenorio C, de Alarcón A, Grupo para el Estudio de las Infecciones Cardiovasculares de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI) (2010) Prognostic factors in left-sided endocarditis: results from the Andalusian multicenter cohort. BMC Infect Dis 10:1–8CrossRef
14.
Zurück zum Zitat Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T et al (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638CrossRefPubMed Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T et al (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638CrossRefPubMed
15.
Zurück zum Zitat Marín M, Muñoz P, Sanchez M, del Rosal M, Alcalá L, Rodríguez Créixems M, Group for the Management of Infective Endocarditis of the Gregorio Marañón Hospital et al (2007) Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue. Medicine (Baltimore) 86:195–202CrossRef Marín M, Muñoz P, Sanchez M, del Rosal M, Alcalá L, Rodríguez Créixems M, Group for the Management of Infective Endocarditis of the Gregorio Marañón Hospital et al (2007) Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue. Medicine (Baltimore) 86:195–202CrossRef
17.
Zurück zum Zitat Ben-Ami R, Giladi M, Carmeli Y, Orni-Wasserlauf R, SiegmanIgra Y (2004) Hospital-acquired infective endocarditis. Should the definition be broadened? Clin Infect Dis 38:843–850CrossRefPubMed Ben-Ami R, Giladi M, Carmeli Y, Orni-Wasserlauf R, SiegmanIgra Y (2004) Hospital-acquired infective endocarditis. Should the definition be broadened? Clin Infect Dis 38:843–850CrossRefPubMed
18.
Zurück zum Zitat Lomas JM, Martínez-Marcos FJ, Plata A, Ivanova R, Galvez J, Ruiz J et al (2010) Healthcare-associated infective endocarditis: an undesirable effect of healthcare universalization. Clin Microbiol Infect 16:1683–1690CrossRefPubMed Lomas JM, Martínez-Marcos FJ, Plata A, Ivanova R, Galvez J, Ruiz J et al (2010) Healthcare-associated infective endocarditis: an undesirable effect of healthcare universalization. Clin Microbiol Infect 16:1683–1690CrossRefPubMed
19.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRef
20.
Zurück zum Zitat Ho KK, Pinsky JL, Kannel WB, Levy D (1993) The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 22:6A–13ACrossRefPubMed Ho KK, Pinsky JL, Kannel WB, Levy D (1993) The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 22:6A–13ACrossRefPubMed
21.
Zurück zum Zitat Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637CrossRef Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:580–637CrossRef
22.
Zurück zum Zitat Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11(2):R31CrossRefPubMedPubMedCentral Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11(2):R31CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E et al (1999) Risk factors and outcome in European cardiac surgery: analysis of the Euro Score multinational database of 19030 patients. Eur J Cardiothorac Surg 15:816–812CrossRefPubMed Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E et al (1999) Risk factors and outcome in European cardiac surgery: analysis of the Euro Score multinational database of 19030 patients. Eur J Cardiothorac Surg 15:816–812CrossRefPubMed
25.
Zurück zum Zitat van Hal SJ, Paterson DL, Lodise TP (2013) Systematic review and meta-analysis of vancomycin –induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antomicrob Agents Chemoter 57:733–744 van Hal SJ, Paterson DL, Lodise TP (2013) Systematic review and meta-analysis of vancomycin –induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antomicrob Agents Chemoter 57:733–744
26.
Zurück zum Zitat Satoskar AA, Nadasdy G, Plaza JA, Sedmak D, Shidham G, Hebert L, Nadasdy T (2006) Staphylococcus infection- associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol:1179–1186 Satoskar AA, Nadasdy G, Plaza JA, Sedmak D, Shidham G, Hebert L, Nadasdy T (2006) Staphylococcus infection- associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol:1179–1186
27.
Zurück zum Zitat Jun-Hua Y-WF, Ynag A-H, Tsai MH (2016) Devastating renal outcome caused by skin infection with methicillin-resistant Stapylococcus aureus. A case report. Medicine 95:26 (e4023)CrossRef Jun-Hua Y-WF, Ynag A-H, Tsai MH (2016) Devastating renal outcome caused by skin infection with methicillin-resistant Stapylococcus aureus. A case report. Medicine 95:26 (e4023)CrossRef
28.
Zurück zum Zitat Fernández-Hidalgo N, Ribera A, Larrosa MN, Vedma E, Origüer J et al (2018) Impact of Staphylococcus aureus phenotype and genotype on the clinical characteristics and outcome of infective endocarditis. A multicentre, longitudinal, prospective, observational study. Clin Microbiol Infect 24(9):985–991CrossRefPubMed Fernández-Hidalgo N, Ribera A, Larrosa MN, Vedma E, Origüer J et al (2018) Impact of Staphylococcus aureus phenotype and genotype on the clinical characteristics and outcome of infective endocarditis. A multicentre, longitudinal, prospective, observational study. Clin Microbiol Infect 24(9):985–991CrossRefPubMed
Metadaten
Titel
Left-sided infective endocarditis caused by Streptococcus agalactiae: rare and serious
verfasst von
Radka Ivanova-Georgieva
Josefa Ruiz-Morales
Emilio García-Cabrera
María Victoria García-López
Juan Gálvez-Acebal
Antonio Plata-Ciezar
Javier de la Torre Lima
Carmen Hidalgo-Tenorio
Francisco Javier Martínez-Marcos
David Vinuesa García
Rafael Luque
Arístides de Alarcón González
Publikationsdatum
14.11.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 2/2019
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3423-3

Weitere Artikel der Ausgabe 2/2019

European Journal of Clinical Microbiology & Infectious Diseases 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.